2.32 USD
+0.08 (+3.57%)
2.32 USD
0 (0%)
STXS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of STXS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, STXS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
STXS had negative earnings in the past year.
STXS had a negative operating cash flow in the past year.
STXS had negative earnings in each of the past 5 years.
In the past 5 years STXS always reported negative operating cash flow.
1.2 Ratios
STXS has a worse Return On Assets (-59.84%) than 69.68% of its industry peers.
STXS has a Return On Equity of -364.90%. This is in the lower half of the industry: STXS underperforms 78.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.84% | ||
| ROE | -364.9% | ||
| ROIC | N/A |
ROA(3y)-47.89%
ROA(5y)-35.58%
ROE(3y)-127.97%
ROE(5y)-86.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
STXS has a Gross Margin (50.17%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of STXS has declined.
The Profit Margin and Operating Margin are not available for STXS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.17% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.5%
GM growth 5Y-7.2%
2. Health
2.1 Basic Checks
STXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for STXS has been increased compared to 1 year ago.
Compared to 5 years ago, STXS has more shares outstanding
There is no outstanding debt for STXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
STXS has an Altman-Z score of -16.80. This is a bad value and indicates that STXS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -16.80, STXS is doing worse than 85.64% of the companies in the same industry.
STXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.8 |
ROIC/WACCN/A
WACC8.7%
2.3 Liquidity
STXS has a Current Ratio of 1.06. This is a normal value and indicates that STXS is financially healthy and should not expect problems in meeting its short term obligations.
STXS's Current ratio of 1.06 is on the low side compared to the rest of the industry. STXS is outperformed by 88.30% of its industry peers.
A Quick Ratio of 0.59 indicates that STXS may have some problems paying its short term obligations.
STXS has a Quick ratio of 0.59. This is amonst the worse of the industry: STXS underperforms 91.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.59 |
3. Growth
3.1 Past
The earnings per share for STXS have decreased by 0.00% in the last year.
The Revenue has been growing slightly by 0.55% in the past year.
STXS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.41% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)0.55%
Revenue growth 3Y-8.4%
Revenue growth 5Y-1.41%
Sales Q2Q%-18.83%
3.2 Future
The Earnings Per Share is expected to grow by 23.07% on average over the next years. This is a very strong growth
Based on estimates for the next years, STXS will show a very strong growth in Revenue. The Revenue will grow by 43.23% on average per year.
EPS Next Y21.8%
EPS Next 2Y21.13%
EPS Next 3Y23.07%
EPS Next 5YN/A
Revenue Next Year26.96%
Revenue Next 2Y37.94%
Revenue Next 3Y43.23%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for STXS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STXS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as STXS's earnings are expected to grow with 23.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.13%
EPS Next 3Y23.07%
5. Dividend
5.1 Amount
STXS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.32
+0.08 (+3.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners46.25%
Inst Owner Change2.78%
Ins Owners19.52%
Ins Owner Change5.06%
Market Cap216.50M
Revenue(TTM)26.92M
Net Income(TTM)-24.64M
Analysts82.22
Price Target4.34 (87.07%)
Short Float %4.78%
Short Ratio5.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.96%
Min EPS beat(2)5.34%
Max EPS beat(2)24.59%
EPS beat(4)2
Avg EPS beat(4)-13.8%
Min EPS beat(4)-49.39%
Max EPS beat(4)24.59%
EPS beat(8)3
Avg EPS beat(8)-12.25%
EPS beat(12)5
Avg EPS beat(12)-9.56%
EPS beat(16)7
Avg EPS beat(16)-10.57%
Revenue beat(2)2
Avg Revenue beat(2)6.35%
Min Revenue beat(2)6.15%
Max Revenue beat(2)6.54%
Revenue beat(4)3
Avg Revenue beat(4)9.1%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)26.98%
Revenue beat(8)3
Avg Revenue beat(8)-4.79%
Revenue beat(12)4
Avg Revenue beat(12)-4.19%
Revenue beat(16)6
Avg Revenue beat(16)-3.64%
PT rev (1m)-5.56%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.13%
EPS NY rev (3m)14.81%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.81 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 32.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.34
BVpS0.07
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.84% | ||
| ROE | -364.9% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.17% | ||
| FCFM | N/A |
ROA(3y)-47.89%
ROA(5y)-35.58%
ROE(3y)-127.97%
ROE(5y)-86.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.5%
GM growth 5Y-7.2%
F-Score4
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 2.39% | ||
| Cap/Sales | 0.11% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.59 | ||
| Altman-Z | -16.8 |
F-Score4
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)206.17%
Cap/Depr(5y)389.02%
Cap/Sales(3y)3.32%
Cap/Sales(5y)2.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y21.8%
EPS Next 2Y21.13%
EPS Next 3Y23.07%
EPS Next 5YN/A
Revenue 1Y (TTM)0.55%
Revenue growth 3Y-8.4%
Revenue growth 5Y-1.41%
Sales Q2Q%-18.83%
Revenue Next Year26.96%
Revenue Next 2Y37.94%
Revenue Next 3Y43.23%
Revenue Next 5YN/A
EBIT growth 1Y-12.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.75%
OCF growth 3YN/A
OCF growth 5YN/A
STEREOTAXIS INC / STXS FAQ
What is the ChartMill fundamental rating of STEREOTAXIS INC (STXS) stock?
ChartMill assigns a fundamental rating of 2 / 10 to STXS.
What is the valuation status for STXS stock?
ChartMill assigns a valuation rating of 1 / 10 to STEREOTAXIS INC (STXS). This can be considered as Overvalued.
What is the profitability of STXS stock?
STEREOTAXIS INC (STXS) has a profitability rating of 0 / 10.
How financially healthy is STEREOTAXIS INC?
The financial health rating of STEREOTAXIS INC (STXS) is 4 / 10.
What is the expected EPS growth for STEREOTAXIS INC (STXS) stock?
The Earnings per Share (EPS) of STEREOTAXIS INC (STXS) is expected to grow by 21.8% in the next year.